Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Stock Forecast

Stock Price Forecast

The 7 analysts that cover Adaptive Biotechnologies stock have a consensus rating of "Strong Buy" and an average price target of $10.57, which forecasts a 0.96% increase in the stock price over the next year. The lowest target is $6 and the highest is $15.

Price Target: $10.57 (+0.96%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$10.57	$10	$15
Change	-42.69%	+0.96%	-4.49%	+43.27%

Analyst Ratings

The average analyst rating for Adaptive Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	1	1	2	2	2	3
Buy	2	3	3	3	3	3
Hold	1	1	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	5	5	5	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
John Wilkin Craig-Hallum	Craig-Hallum	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+43.27%	Jun 18, 2025
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $11 → $13	Buy	Maintains	$11 → $13	+24.16%	May 6, 2025
Tejas Savant Morgan Stanley	Morgan Stanley	Hold Maintains $7 → $9	Hold	Maintains	$7 → $9	-14.04%	May 5, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Strong Buy Maintains $9 → $10	Strong Buy	Maintains	$9 → $10	-4.49%	May 2, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Hold → Strong Buy Upgrades $8 → $9	Hold → Strong Buy	Upgrades	$8 → $9	-14.04%	Mar 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

222.73M

Increased by 24.46%

from 178.96M

Revenue Next Year

267.83M

Increased by 20.25%

from 222.73M

EPS This Year

-0.87

from -1.08

EPS Next Year

-0.66

from -0.87

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	98.38M	154.34M	185.31M	170.28M	178.96M	222.73M	267.83M	336.65M
Revenue Growth	15.65%	56.88%	20.06%	-8.11%	5.10%	24.46%	20.25%	25.70%
EPS	-1.11	-1.48	-1.40	-1.56	-1.08	-0.87	-0.66	-0.37
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	9	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	234.3M	293.2M	369.2M
Avg	222.7M	267.8M	336.7M
Low	209.4M	238.6M	304.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	30.9%	31.6%	37.8%
Avg	24.5%	20.2%	25.7%
Low	17.0%	7.1%	13.5%

EPS Forecast

EPS	2025	2026	2027
High	-0.85	-0.49	-0.22
Avg	-0.87	-0.66	-0.37
Low	-0.89	-0.86	-0.46

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.